TABLE 1.
Source of cells | Accessibility | Ethical concerns | Tumorigenic | Autologous | Nervous system-derived |
NSPCs | Low | Moderate | Sometimes | Sometimes | Yes |
ESCs | Low | Significant | Yes | No | No |
iPSCs | High | None | Yes | Yes | No |
MSCs | High | None | No | Yes | No |
HSCs | High | None | No | Yes | No |
DPSCs | High | None | No | Yes | No |
ENSCs | High | None | No | Yes | Yes |
SAT-NSCs | High | None | No | Yes | Yes |
NSPCs, neural stem/progenitor cells; ESCs, embryonic stem cells; iPSCs, induced pluripotent stem cells; MSCs, mesenchymal stem cells; HSCs, hematopoietic stem cells; DPSCs, dental pulp stem cells; ENSCs, enteric neuronal stem cells; SAT-NSCs, subcutaneous adipose tissue–neural stem cells.